November 2020 - Page 16 of 27

ThursdayNov 12, 2020 1:58 pm

VistaGen Therapeutics Inc. (NASDAQ: VTGN) CEO Discusses ‘Game-Changing’ Potential of Drug Pipeline Lineup in Stock2Me Podcast

VTGN is committed to developing and commercializing differentiated new generation medications that go beyond the current standard of care for anxiety, depression and other CNS disorders. VTGN currently has three drugs in its pipeline, PH94B and PH10, both innovative synthetic neuroactive steroid nasal sprays, and AV-101, a novel, oral prodrug that targets the NMDAR. VTGN has opportunity, based on current drug-development programs, to “shift the paradigm.” VistaGen Therapeutics (NASDAQ: VTGN) CEO Shawn Singh spoke about VistaGen’s game-changing potential for the treatment of mental illness during a recent episode of InvestorBrandNetwork’s Stock2Me Podcast (https://ibn.fm/34My5). A clinical-stage biopharmaceutical company, VTGN has three drugs…

ThursdayNov 12, 2020 1:53 pm

QualityStocksNewsBreaks – The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) Announces Supply Agreement with Medical Cannabis by Shoppers

The Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) will be providing its Truverra-branded medical cannabis products to patients across Canada. The company will be doing so based on a just-announced supply agreement with Medical Cannabis by Shoppers Inc., a subsidiary of Shoppers Drug Mart Inc. SPRWF’s Truverra products will be available through the Medical Cannabis by Shoppers(TM) online sales platform. A convenient and accessible source of medical cannabis, the platform offers patients a single-source access to a broad range of high-quality products. Using the platform, patients can find and order cannabis products that meet high quality and safety standards; the…

ThursdayNov 12, 2020 1:39 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) to Present at Virtual Fall Investor Summit

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the current leading U.S. producer of uranium, the top U.S. producer of vanadium in 2019, and focused on the potential to begin producing a rare earth element (“REE”) concentrate at its White Mesa Mill, will be presenting at this year's virtual Fall Investor Summit. The event is slated to take place from Nov. 16-18 in a virtual format and feature 75 companies and over 300 institutional and retail investors. Interested parties should visit https://ibn.fm/fpEn2 for more details and to register for the Fall Investor Summit. To view the full press release, visit https://ibn.fm/7P3B8 About…

ThursdayNov 12, 2020 1:07 pm

QualityStocksNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Present at Virtual Fall Investor Summit

MustGrow (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture bio-tech company focused on providing natural, science-based biological solutions to replace synthetic chemicals, today announced that it will be presenting at this year's virtual Fall Investor Summit. The event is slated to take place from Nov. 16-18t, 2020, and will take place virtually and feature 75 companies and over 300 institutional and retail investors. To view the full press release, visit https://ibn.fm/j6ivt About MustGrow MustGrow is a publicly traded agriculture biotech company focused on providing natural science-based biological solutions for high value crops, including fruits and vegetables. MustGrow has designed and…

ThursdayNov 12, 2020 12:42 pm

QualityStocksNewsBreaks – Rritual Receives USDA Organic Certification, Official Confirmation of Product Quality

Rritual announced that it has received the United States Department of Agriculture (“USDA”) Organic Certification. Awarded only after a demanding vetting process, the seal confirms the high quality of Rritual’s product lineup and manufacturing process. Rritual launched its original product lineup in September, which features products formulated with mindfully selected functional mushrooms and adaptogenic herbs. The products are designed to help relieve stress, improve cognitive function and support the immune system. As a Certified Organic company, Rritual meets a strict process that verifies its ingredients are free from antibiotics, toxic pesticides, synthetic hormones and genetically modified organisms (“GMOs”). In addition, Rritual…

ThursdayNov 12, 2020 12:30 pm

QualityStocksNewsBreaks – Sustainable Green Team Ltd. (SGTM) Announces Expansion of Mulch Contract with Circle K Convenient Stores

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, today announced that its wholly owned subsidiary Mulch Manufacturing Inc. has expanded its 2021 mulch contracts with Circle K convenient stores, a subsidiary of Alimentation Couche-Tard Inc. (OTC: ANCUF) (“ANCUF”). According to the update, the original contract finalized in October was increased to add an additional region to the initial three, bringing the total to four. SGTM obtained the mulch contract expansion shortly after reporting another successful quarter in which it generated approximately $24.5 million in revenue and $5.5 million in gross…

ThursdayNov 12, 2020 12:02 pm

QualityStocksNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Reports Positive Preclinical Data on PH94B’s Mechanism of Action

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today announced new in vitro electrophysiology data. According to the update, the data demonstrate that the mechanism of action of PH94B, the intranasal neuroactive steroid the company is preparing for Phase 3 development as a potential acute rapid-onset treatment of anxiety in adults with social anxiety disorder, does not involve direct activation of GABA-A receptors, in distinct contrast to the mechanism of action of benzodiazepines (“benzos”), which act as direct positive modulators of GABA-A receptors. “We are very pleased with…

ThursdayNov 12, 2020 11:31 am

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Financial Results for Third Quarter

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has released its financial results for Q3 2020. In addition, the company reported on important third-quarter highlights and provided an update on key objectives. Dario ended the third quarter with cash and cash equivalents of $37 million and plans to focus on its U.S. commercial sales and marketing infrastructure with the end goal of B2B2C pipeline growth. In addition, through its agreements with Vitality Group and HMC Healthworks, the company is committed to becoming a B2B2C digital therapeutics leader. The report also noted that Eric Milledge had been appointed…

ThursdayNov 12, 2020 11:07 am

QualityStocksNewsBreaks – PowerBand Solutions Inc.’s (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) DRIVRZ Provides 14-Day Return, Exchange Option

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), a fintech provider disrupting the automotive industry, today announced that its virtual transaction platform will now offer drivers up to 14 days to return and exchange a car or truck they are not satisfied with. According to the update, drivers who lease a car or truck on PowerBand's virtual transaction platform - now branded as DRIVRZ - will be able to return their vehicles within 14 days if they are unsatisfied with their first choice for any reason. Drivers will be able to exchange their vehicle for one of similar or greater…

ThursdayNov 12, 2020 10:41 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Hosting Webcast for Discussion of Phase 2 Clinical Trial Design

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, has scheduled a webcast today during which it will be discussing its plan to submit a phase 2 clinical trial design for FDA review. The call, which will be moderated by Robert LeBoyer, managing director of Equity Research at Ladenburg Thalmann & Co. Inc., will start at 4:30 p.m. ET. The phase 2 trial design is for the U.S. trial for CNSP’s Berubicin. Berubicin is the company’s lead drug candidate for the treatment of glioblastoma multiforme…

Site Search

Company Search

Month: November 2020